Skip to search formSkip to main contentSkip to account menu

NIK-333

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
To improve the outcome of cancer chemotherapy, strategies to enhance the efficacy of anticancer drugs are required. Sorafenib is… 
2013
2013
Development of an effective low-cost anti-acquired immunodeficiency syndrome (AIDS) drugs is needed for treatment of AIDS… 
2011
2011
Aim:  NIK‐333 (an acyclic retinoid) has been reported to prevent recurrence of hepatocellular carcinoma (HCC) in patients after… 
2009
2009
BACKGROUND & AIMS We previously reported that impaired retinoid signaling in the liver causes steatohepatitis and hepatocellular… 
2006
2006
Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type I (HTLV-I) and remains incurable. NIK-333, a novel… 
2005
2005
Abstract: We investigated the preventive effects of a synthetic acyclic retinoid, NIK-333, on the early and late events of… 
2004
2004
The present study was designed to determine the effects of NIK-333, a synthetic acyclic retinoid, on N-diethylnitrosamine (DEN…